Michael & Susan Dell Foundation Diversified Active

CIK: 0001599858 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $70,081 (100.0% shares, 0.0% debt)

Holdings (6)

JPM JPMORGAN CHASE & CO 46.7%

Value ($000) $32,703 Shares 313,853 Est. Cost $50.34 Unrealized +76.8%

— AETNA INC NEW 22.6%

Value ($000) $15,835 Shares 86,296 Est. Cost $68.59 Unrealized —

PVH PVH CORP 11.3%

Value ($000) $7,934 Shares 52,995 Est. Cost $155.66 Unrealized 0.0%

BRK/B BERKSHIRE HATHAWAY INC DEL 10.5%

Value ($000) $7,373 Shares 39,500 Est. Cost $132.58 Unrealized +47.0%

— INTREXON CORP 8.6%

Value ($000) $6,034 Shares 432,878 Est. Cost $25.55 Unrealized —

— ZIOPHARM ONCOLOGY INC 0.3%

Value ($000) $202 Shares 66,749 Est. Cost $12.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
JPM	JPMORGAN CHASE & CO	313,853	$32,703	46.7%	$50.34	+76.8%	COM	46625H100
—	AETNA INC NEW	86,296	$15,835	22.6%	$68.59	—	COM	00817Y108
PVH	PVH CORP	52,995	$7,934	11.3%	$155.66	0.0%	COM	693656100
BRK/B	BERKSHIRE HATHAWAY INC DEL	39,500	$7,373	10.5%	$132.58	+47.0%	CL B NEW	084670702
—	INTREXON CORP	432,878	$6,034	8.6%	$25.55	—	COM	46122T102
—	ZIOPHARM ONCOLOGY INC	66,749	$202	0.3%	$12.00	—	COM	98973P101